US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 6.340
  • +0.460+7.82%
Close Nov 27 16:00 ET
538.51MMarket Cap-5372P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.50%-16.46M
-24.52%-16.18M
-58.52%-22.8M
-37.23%-67.39M
-72.30%-19.32M
-54.06%-20.7M
-16.40%-12.99M
-8.14%-14.38M
-17.41%-49.11M
-5.08%-11.21M
Net income from continuing operations
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
Depreciation and amortization
-7.21%206K
10.60%240K
6.31%236K
-14.63%881K
-5.58%220K
-11.90%222K
-19.33%217K
-20.14%222K
101.56%1.03M
104.39%233K
Deferred tax
6.25%34K
6.25%34K
6.25%34K
-64.03%141K
-87.25%45K
128.57%32K
700.00%32K
52.38%32K
79.00%392K
102.87%353K
Change In working capital
131.14%1.1M
73.93%2.43M
-216.04%-4.36M
224.49%1.29M
-118.12%-345K
-868.56%-3.52M
746.30%1.4M
218.13%3.76M
27.23%-1.04M
248.08%1.9M
-Change in prepaid assets
206.04%1.21M
152.26%300K
-1,764.18%-1.25M
-71.36%-1.92M
-111.61%-137K
-148.48%-1.14M
-1,203.85%-574K
96.46%-67K
-571.01%-1.12M
87.60%1.18M
-Change in payables and accrued expense
105.12%113K
8.11%2.31M
-173.66%-2.94M
458.79%3.88M
-104.32%-38K
-304.83%-2.21M
1,861.98%2.13M
449.69%3.99M
142.32%694K
899.09%879K
-Change in other current liabilities
-33.92%-229K
-9.26%-177K
-7.36%-175K
-9.18%-666K
-9.68%-170K
-7.55%-171K
-10.20%-162K
-9.40%-163K
---610K
---155K
Cash from discontinued investing activities
Operating cash flow
20.50%-16.46M
-24.52%-16.18M
-58.52%-22.8M
-37.23%-67.39M
-72.30%-19.32M
-54.06%-20.7M
-16.40%-12.99M
-8.14%-14.38M
-17.41%-49.11M
-5.08%-11.21M
Investing cash flow
Cash flow from continuing investing activities
242.29%31.75M
146.45%42.19M
-71.37%8M
-70.56%-37.99M
424.71%47.23M
-1,699.44%-22.31M
-468.66%-90.84M
194.38%27.93M
81.39%-22.27M
-126.54%-14.55M
Net PPE purchase and sale
--0
---13K
---29K
81.09%-52K
-29.41%-44K
-200.00%-8K
--0
--0
19.12%-275K
83.00%-34K
Net investment purchase and sale
242.34%31.75M
146.46%42.2M
-71.26%8.03M
-72.46%-37.94M
425.77%47.28M
-1,687.26%-22.31M
-468.90%-90.84M
187.06%27.93M
81.57%-22M
-133.27%-14.51M
Cash from discontinued investing activities
Investing cash flow
242.29%31.75M
146.45%42.19M
-71.37%8M
-70.56%-37.99M
424.71%47.23M
-1,699.44%-22.31M
-468.66%-90.84M
194.38%27.93M
81.39%-22.27M
-126.54%-14.55M
Financing cash flow
Cash flow from continuing financing activities
816,360.00%163.29M
-18.40%399K
0
-74.89%41.95M
-86.92%13.86M
-99.97%20K
294.35%489K
27.58M
24.33%167.1M
662,212.50%105.97M
Net common stock issuance
--162.31M
--0
--0
-75.12%41.61M
-87.10%13.69M
--0
--0
--27.92M
22.65%167.25M
--106.11M
Proceeds from stock option exercised by employees
5,175.00%1.06M
----
----
181.48%684K
47.06%175K
--20K
----
----
-73.41%243K
643.75%119K
Net other financing activities
----
----
----
14.21%-344K
--0
--0
--0
---344K
-104.01%-401K
---257K
Cash from discontinued financing activities
Financing cash flow
816,360.00%163.29M
-18.40%399K
--0
-74.89%41.95M
-86.92%13.86M
-99.97%20K
294.35%489K
--27.58M
24.33%167.1M
662,212.50%105.97M
Net cash flow
Beginning cash position
13.07%91.5M
-64.69%65.1M
-44.20%79.93M
200.29%143.24M
-39.83%37.89M
381.49%80.92M
320.14%184.35M
200.29%143.24M
-36.28%47.7M
-2.74%62.98M
Current changes in cash
515.40%178.59M
125.56%26.41M
-135.99%-14.8M
-166.27%-63.43M
-47.92%41.78M
-192.81%-42.99M
-282.57%-103.34M
1,178.93%41.13M
452.80%95.71M
569.80%80.21M
Effect of exchange rate changes
255.88%53K
85.11%-14K
-160.00%-26K
165.73%117K
466.67%255K
77.92%-34K
-54.10%-94K
-25.00%-10K
-612.00%-178K
104.55%45K
End cash Position
612.89%270.14M
13.07%91.5M
-64.69%65.1M
-44.20%79.93M
-44.20%79.93M
-39.83%37.89M
381.49%80.92M
320.14%184.35M
200.29%143.24M
200.29%143.24M
Free cash flow
20.53%-16.46M
-24.62%-16.19M
-58.72%-22.83M
-36.57%-67.44M
-72.17%-19.36M
-54.21%-20.71M
-16.33%-12.99M
-6.20%-14.38M
-17.12%-49.38M
-3.46%-11.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.50%-16.46M-24.52%-16.18M-58.52%-22.8M-37.23%-67.39M-72.30%-19.32M-54.06%-20.7M-16.40%-12.99M-8.14%-14.38M-17.41%-49.11M-5.08%-11.21M
Net income from continuing operations 26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M
Depreciation and amortization -7.21%206K10.60%240K6.31%236K-14.63%881K-5.58%220K-11.90%222K-19.33%217K-20.14%222K101.56%1.03M104.39%233K
Deferred tax 6.25%34K6.25%34K6.25%34K-64.03%141K-87.25%45K128.57%32K700.00%32K52.38%32K79.00%392K102.87%353K
Change In working capital 131.14%1.1M73.93%2.43M-216.04%-4.36M224.49%1.29M-118.12%-345K-868.56%-3.52M746.30%1.4M218.13%3.76M27.23%-1.04M248.08%1.9M
-Change in prepaid assets 206.04%1.21M152.26%300K-1,764.18%-1.25M-71.36%-1.92M-111.61%-137K-148.48%-1.14M-1,203.85%-574K96.46%-67K-571.01%-1.12M87.60%1.18M
-Change in payables and accrued expense 105.12%113K8.11%2.31M-173.66%-2.94M458.79%3.88M-104.32%-38K-304.83%-2.21M1,861.98%2.13M449.69%3.99M142.32%694K899.09%879K
-Change in other current liabilities -33.92%-229K-9.26%-177K-7.36%-175K-9.18%-666K-9.68%-170K-7.55%-171K-10.20%-162K-9.40%-163K---610K---155K
Cash from discontinued investing activities
Operating cash flow 20.50%-16.46M-24.52%-16.18M-58.52%-22.8M-37.23%-67.39M-72.30%-19.32M-54.06%-20.7M-16.40%-12.99M-8.14%-14.38M-17.41%-49.11M-5.08%-11.21M
Investing cash flow
Cash flow from continuing investing activities 242.29%31.75M146.45%42.19M-71.37%8M-70.56%-37.99M424.71%47.23M-1,699.44%-22.31M-468.66%-90.84M194.38%27.93M81.39%-22.27M-126.54%-14.55M
Net PPE purchase and sale --0---13K---29K81.09%-52K-29.41%-44K-200.00%-8K--0--019.12%-275K83.00%-34K
Net investment purchase and sale 242.34%31.75M146.46%42.2M-71.26%8.03M-72.46%-37.94M425.77%47.28M-1,687.26%-22.31M-468.90%-90.84M187.06%27.93M81.57%-22M-133.27%-14.51M
Cash from discontinued investing activities
Investing cash flow 242.29%31.75M146.45%42.19M-71.37%8M-70.56%-37.99M424.71%47.23M-1,699.44%-22.31M-468.66%-90.84M194.38%27.93M81.39%-22.27M-126.54%-14.55M
Financing cash flow
Cash flow from continuing financing activities 816,360.00%163.29M-18.40%399K0-74.89%41.95M-86.92%13.86M-99.97%20K294.35%489K27.58M24.33%167.1M662,212.50%105.97M
Net common stock issuance --162.31M--0--0-75.12%41.61M-87.10%13.69M--0--0--27.92M22.65%167.25M--106.11M
Proceeds from stock option exercised by employees 5,175.00%1.06M--------181.48%684K47.06%175K--20K---------73.41%243K643.75%119K
Net other financing activities ------------14.21%-344K--0--0--0---344K-104.01%-401K---257K
Cash from discontinued financing activities
Financing cash flow 816,360.00%163.29M-18.40%399K--0-74.89%41.95M-86.92%13.86M-99.97%20K294.35%489K--27.58M24.33%167.1M662,212.50%105.97M
Net cash flow
Beginning cash position 13.07%91.5M-64.69%65.1M-44.20%79.93M200.29%143.24M-39.83%37.89M381.49%80.92M320.14%184.35M200.29%143.24M-36.28%47.7M-2.74%62.98M
Current changes in cash 515.40%178.59M125.56%26.41M-135.99%-14.8M-166.27%-63.43M-47.92%41.78M-192.81%-42.99M-282.57%-103.34M1,178.93%41.13M452.80%95.71M569.80%80.21M
Effect of exchange rate changes 255.88%53K85.11%-14K-160.00%-26K165.73%117K466.67%255K77.92%-34K-54.10%-94K-25.00%-10K-612.00%-178K104.55%45K
End cash Position 612.89%270.14M13.07%91.5M-64.69%65.1M-44.20%79.93M-44.20%79.93M-39.83%37.89M381.49%80.92M320.14%184.35M200.29%143.24M200.29%143.24M
Free cash flow 20.53%-16.46M-24.62%-16.19M-58.72%-22.83M-36.57%-67.44M-72.17%-19.36M-54.21%-20.71M-16.33%-12.99M-6.20%-14.38M-17.12%-49.38M-3.46%-11.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data